Chapter 20 - Hypothalamus and weight loss in amyotrophic lateral sclerosis - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Book Sections Year : 2021

Chapter 20 - Hypothalamus and weight loss in amyotrophic lateral sclerosis

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disorder. While initially pathophysiology was thought to be restricted to motor deficits, it is increasingly recognized that patients develop prominent changes in weight and eating behavior that result from and mediate the underlying neurodegenerative process. These changes include alterations in metabolism, lipid levels, and insulin resistance. Emerging research suggests that these alterations may be mediated through changes in the hypothalamic function, with atrophy of the hypothalamus shown in both ALS patients and also presymptomatic genetic at-risk patients. This chapter reviews the evidence for hypothalamic involvement in ALS, including melanocortin pathways and potential treatment targets.
No file

Dates and versions

inserm-03376349 , version 1 (13-10-2021)

Identifiers

Cite

Rebekah Ahmed, Frederik Steyn, Luc Dupuis. Chapter 20 - Hypothalamus and weight loss in amyotrophic lateral sclerosis. The Human Hypothalamus - Middle and Posterior Region, 180, Elsevier, pp.327-338, 2021, Handbook of Clinical Neurology, ⟨10.1016/B978-0-12-820107-7.00020-3⟩. ⟨inserm-03376349⟩

Collections

INSERM SITE-ALSACE
21 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More